
















































of	 intravascular	ultrasound	 (IVUS)	 imaging.	The	application	of	 this	 technique	 in	 the	clinical	 setting	heightened	our	
appreciation	of	the	limitations	of	coronary	angiography	in	assessing	the	severity	of	a	lesion	and	plaque	morphology,	
and	 emphasized	 the	 need	 to	 develop	 alternative	 imaging	modalities	 for	 studying	 coronary	 plaque	 characteristics.	




intravascular	magnetic	 resonance	 imaging,	near	 infrared	 fluorescence	 imaging,	and	 fluorescence	 lifetime	 imaging).	
Histology-based	and	clinical	studies	have	provided	robust	evidence	about	the	clinical	and	research	potential	of	the	
clinically	applicable	modalities	but	also	revealed	their	limitations	in	the	study	of	atherosclerosis	(see	Supplementary	
data	online,	Supplementary	Data).	To	overcome	 the	 inherent	drawbacks	of	 the	existing	 techniques,	multimodality	
intravascular	imaging	was	proposed	in	order	to	synergize	their	strengths	for	better	assessment	of	plaque	morphology	
and	 vulnerability	 (Figure	 1).	 Today,	 several	 dualprobe	 catheters	 have	 been	 developed	 that	 enable	 combined	
intravascular	imaging	of	plaque	pathobiology.1	
	
























group	 implemented	 serial	 combined	 IVUS-OCT	 imaging	 in	 24	 patients	 to	 study	 bifurcation	 lesions	 and	 found	 no	







with	a	mild	 (30–49%)	or	moderate	stenosis	 (50–69%).8	These	results	 indicate	 that	severely	stenotic	 lesions	have	a	







patients	 were	 included	 in	 the	 analysis.	 There	were	 no	 differences	 between	 the	 three	 groups	 in	 the	 incidence	 of	
macrophages,	neo-vessels,	calcifications,	and	cholesterols	crystals.	Ruptured	plaques	more	often	had	thrombus,	and	


















Three	 prospective	 studies	 used	 combined	 IVUS	 and	 OCT	 imaging	 to	 examine	 the	 effect	 of	 statin	 therapy	 on	 the	
compositional	characteristics	of	the	plaque,	with	the	Integrated	Biomarkers	Imaging	Study	4	(IBIS	4),	being	the	largest	
study	of	its	kind	(see	Supplementary	data	online,	Table	S1).	IBIS	4	used	combined	3-vessel	RF-IVUS	and	OCT	imaging	
to	assess	plaque	morphology	and	characteristics	 in	patients	with	a	ST-elevation	myocardial	 infarction	 (STEMI).12	 It	
included	103	patients	treated	with	high	intensity	rosuvastatin	40	mg	od	who	had	serial	 imaging	at	baseline	and	13	
months	 follow-up.	 The	 results	 from	 the	 IVUS	 analysis–the	 OCT	 analysis	 has	 not	 been	 presented	 yet–showed	 a	
regression	in	the	percent	atheroma	volume	at	13	months	follow-up	(–0.9%,	P=0.007).13	OCT	and	RF-IVUS	imaging	was	
feasible	in	the	vast	majority	of	the	cases	at	both	baseline	(OCT:	89.9%,	RF-IVUS:	85.7%)	and	follow-up	(OCT:	86.6%,	
RF-IVUS:	 84.8%).	 The	 complications	 rates	 were	 low:	 1.9%	 at	 baseline	 and	 1.1%	 at	 follow-up.	 When	 the	 authors	
compared	outcomes	between	patients	who	had	PCI	with	and	without	multimodality	intravascular	imaging	they	found	
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IVUS	 and	 NIRS	 imaging	 was	 performed	 at	 baseline	 and	 at	 7	 weeks	 follow-up	 in	 lesions	 with	 a	 fractional	 flow	




























prototypes	 are	 currently	 under	 development	 including	 the	 combined	 IVUS-OCT,	 NIRS-OCT,	 IVUS-near	 infrared	












evaluation	 of	 plaque	 distribution	 and	 composition.	 The	 catheter	 is	 commercially	 available	 and	 has	 received	 FDA	
approval	 for	 the	 study	 of	 the	 composition	 of	 the	 plaque.	 Several	 reports	 used	 this	 modality	 to	 assess	 plaque	









larger	 scale,	 two	 centre	 study	 including	 75	 patients	 admitted	 with	 a	 STEMI	 has	 confirmed	 the	 above	 findings	
demonstrating	that	the	maximum	lipid	plaque	burden	index	in	a	4	mm	segment	was	able	to	differentiate	culprit	from	
the	non-culprit	lesions	with	a	sensitivity	and	specificity	of	64%	and	85%,	respectively.24	The	same	research	group	has	
reported	 similar	 findings	 in	 patients	 admitted	 with	 non-STEMI	 and	 unstable	 angina:	 NIRS-IVUS	 imaging	 enabled	

















NIRF	 involves	 the	 injection	 of	 activatablemarkers	 that	 have	 the	 ability	 to	 bind	molecules	 associated	 with	 plaque	
vulnerability	and	fluoresce	when	they	are	irradiated	with	near	infrared	light.	Combined	OCT-NIRF	imaging	provides	
unique	opportunities	for	studying	plaque	pathophysiology	as	OCT	is	able	to	assess	luminal	dimensions	and	plaque	





about	 the	 feasibility	 of	 combined	 OCT-NIRF	 imaging	 and	 showed	 that	 NIRF	 enables	 detection	 of	 macrophages	
accumulation	and	fibrin	deposition28,29;	but	none	of	these	markers	have	been	used	in	the	clinical	setting	yet.	
	
In	 a	 recent	 report,	 Wang	 et	 al.	 showed	 that	 necrotic-rich	 plaques	 have	 the	 ability	 to	 fluoresce	 (near	 infrared	
autofluoresnce	imaging–NIRAF)	when	they	are	excited	with	NIRF	light	at	633	nm.30	The	safety	and	the	efficacy	of	OCT-
NIRAF	 in	the	characterization	of	atherosclerosis	was	been	tested	 in	a	small	study	 involving	12	patients	undergoing	
PCI.31	The	acquired	NIRAF	emission	intensities	were	co-registered	offline	with	the	OCT	imaging	data.	A	strong	NIRAF	
signal	 was	 seen	 in	 regions	 of	 plaque	 with	 high-risk	 features	 such	 as	 lipid	 containing	 plaques,	 thin-fibrous	 caps,	
macrophages	and	ruptured	plaques	with	overlaying	thrombus.	The	authors	observed	that	not	all	 the	plaques	with	
high-risk	 features	 (i.e.	 macrophages,	 lipid-rich	 lesions)	 had	 increasedNIRAF	 signal	 and	 speculated	 that	 an	
increasedNIRAF	 signal	 may	 be	 a	 new	 imaging	 marker	 associated	 with	 increased	 plaque	 vulnerability	 (Figure	 4).	
Histological	evidence	has	showed	that	NIRAF	may	allow	detection	of	inflamed	plaques	with	oxidized	lipid	component	









importantly	 these	 studies	 eradicated	 false	 beliefs	 about	 the	 morphology	 of	 vulnerable	 plaques,	 furthered	 our	
understanding	of	plaque	vulnerability	and	demonstrated	 that	a	complete	assessment	of	plaque	pathobiology	may	
enable	more	accurate	identification	of	the	lesions	that	will	progress,	rupture	and	cause	cardiovascular	events.	Finally,	
serial	 multimodality	 imaging	 studies	 have	 allowed	 us	 to	 better	 understand	 atherosclerotic	 evolution	 and	 have	 a	
complete	assessment	of	the	effect	of	treatments	on	plaque	burden,	morphology,	and	vulnerability.	
	
However,	 although	 it	 is	 apparent	 that	 multimodality	 intravascular	 imaging	 is	 superior	 to	 standalone	 imaging	 its	
applications	 in	 the	 study	 of	 atherosclerosis	 is	 limited.	 This	 is	 attributed	 to	 the	 risk–despite	 being	 minimal–of	
complications,	 to	 the	 increased	 cost	 and	 time	 required	 for	 multimodality	 intracoronary	 imaging	 of	 the	 coronary	







commenced	and	are	expected	 to	provide	us	with	more	 information	on	 the	potential	 value	of	hybrid	 intravascular	
imaging	in	understanding	the	mechanisms	involved	in	atherosclerotic	plaque	development	and	destabilization	and	in	
detecting	 lesions	 that	 are	 prone	 to	 progress	 and	 cause	 events.	 The	 advent	 of	 new	 hybrid	 imaging	 modalities	 is	
anticipated	to	provide	further	opportunities	to	study	plaque	pathobiology	and	allow	reliable	detection	of	vulnerable	
plaques	 and	 patients	 that	 are	 at	 high	 risk	 to	 sustain	 future	 cardiovascular	 events.	 Preliminary	 uni-modality	
intravascular	imaging	studies	have	provided	proof	of	the	latter	concept33	and	showed	that	a	complete	assessment	of	
coronary	morphology	is	likely	to	enable	more	accurate	risk	stratification	which	would	justify	the	implementation	of	
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Figure	 3	 Output	 of	 different	 hybrid	 intravascular	 imaging	 catheters.	 Co-registered	 IVUS	 (A)	 and	 OCT	 images	 (B)	













h	before	 imaging	was	used	to	detect	for	cathepsin	protease	activity.	Atheroma	was	 induced	 in	the	rabbit	aorta	by	
mechanical	balloon	injury	and	hypercholesterolaemic	diet.	(K)	Cross-sectional	OCT-NIRF	image	(yellow/white	indicates	
high	and	blue/black	low	NIRF	signal)	at	the	location	of	the	white	dotted	line	in	(J).	Matched	fluorescence	microscopy	


























IVUS	 (VH-IVUS),	 iMAP-IVUS	 and	 integrated	 backscatter	 analysis4.	 These	 techniques	 have	 enabled	 more	 reliable	
characterization	of	plaque	composition	and	assessment	of	its	phenotype5.	However,	in	contrast	to	what	it	has	shown	















ability	 to	 discriminate	 between	 deeply	 embedded	 calcific	 and	 lipid	 tissue,	 and	 identifying	 the	 presence	 of	





catheter	 that	 is	advanced	 in	 the	coronary	arteries.	Histology-based	studies	 suggest	 that	NIRS	 is	able	 to	accurately	







that	 it	 does	 not	 enable	 quantification	 of	 plaque	 burden,	 visualization	 of	 the	 lumen	 and	 outer	 vessel	 wall,	 and	













and	 OCT	 in	 detecting	 TCFA	
(defined	 as	 plaques	 that	 met	
both	 the	 RF-IVUS	 and	 OCT	
criteria)	
56	 126	 RF-IVUS	and	OCT	 1.	RF-IVUS	had	only	46%	positive	ratio	in	detecting	TCFA.	Its	limited	accuracy	was	due	to	




Gonzalo	et	al20	 To	 evaluate	 the	 distribution	 of	
different	 plaque	 types	 in	
bifurcations	 using	
multimodality	imaging		





Diletti	et	al21	 To	 assess	 changes	 in	 the	
phenotype	 of	 the	 plaque	 in	
bifurcations		
24	 56	 RF-IVUS	 and	OCT	
at	baseline	and	6-
month	follow-up	




Tian	et	al22	 To	 indentify	 morphological	
characteristics	of	asymptomatic	
TCFA,	 ruptured	 non-culprit	
plaques	 and	 ruptured	 culprit	
plaques	
82	 126	 Grayscale	 IVUS	
and	OCT	
1.	Cap	thickness	was	smaller	in	ruptured	plaques	
2.	Plaque	burden	was	 increased	and	the	 lumen	area	was	smaller	 in	ruptured	plaques	
that	cause	events	
3.	Combined	 IVUS-OCT	 imaging	enabled	prediction	of	plaques	that	will	 rupture	(OCT-
derived	cap	thickness	was	the	best	predictor	of	plaque	rupture)	and	cause	events	(IVUS-
derived	plaque	burden	was	the	best	predictor	of	ruptured	plaques	that	caused	events)	
Tian	et	al23	 To	 investigate	 the	 association	
between	 lesion	 severity	 and	
plaque	morphology	
255	 643	 Grayscale	 IVUS	
and	OCT		






characteristics	 in	 plaques	 that	


























66;	 36	 in	 the	
high	 intensity	














Gin	et	al26	 To	 assess	 the	 effect	 of	 statin		
therapy	 on	 plaque	
characteristics	 in	 patients	 with	







97;	 23	 in	 the	
stable	 angina	

















Taniwaki	et	al27	 To	 examine	 the	 safety	 and	
feasibility	 of	 multimodality	












1.	Multi-modality	serial	 intravascular	 imaging	was	 feasible	 in	 the	vast	majority	of	 the	
culprit	and	non-culprit	vessels	
2.	 Multimodality	 imaging	 was	 safe	 (complication	 rate	 1.9%	 at	 baseline	 and	 1.1%	 at	
follow-up)	
Kini	et	al28	 To	 examine	 in	 obstructive	
lesions	 the	 effect	 of	 aggressive	
lipid	 lowering	 treatment	




























To	 examine	 the	 implications	 of	
aggressive	 lipid	 lowering	
treatment	 (rosuvastatin	 40mg)	





























To	 assess	 the	 accuracy	 of	 NIRS-






2.	 Combined	 NIRS-IVUS	 imaging	 had	 a	 higher	 accuracy	 (sensitivity:	 100%,	 specificity:	 91%)	 in	




To	 examine	 the	 value	 of	 NIRS-
IVUS	 in	 differentiating	 culprit	























To	 assess	 using	 NIRS-IVUS	
morphological	 differences	
between	 culprit	 and	 non-culprit	

















To	 examine	 sex	 differences	 in	








2.	 Men	 had	 increased	 plaque	 burden	 (44.4%	 vs.	 39.3%,	 P=0.031)	 in	 the	 reference	 segment	
compared	to	women	but	not	in	the	minimum	lumen	site	




To	 examine	 the	 safety	 and	
feasibility	of	OCT-NIRAF	imaging	
12	 17	 OCT-NIRAF	 1.	Image	acquisition	was	successful	in	all	the	studied	segments	
2.	There	was	an	excellent	reproducibility	of	the	NIRAF	signal	in	4	segments	that	had	repeated	pull-
backs		
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